An open label clinical trial of reboxetine in patients with major depressive disorder

被引：0
|
作者：
Demir, B
Soykan, A
Devrimci-Ozguven, H
Gögüs, A
Haller, T
机构：
[1] Univ Hacettepe, Dept Psychiat, TR-06100 Ankara, Turkey
[2] Ankara Univ, Dept Psychiat, TR-06100 Ankara, Turkey
[3] Pharmacia Canada, CNS, Markham, ON, Canada
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S221 / S221
页数：1
相关论文
共 50 条
  • [31] The efficacy of reboxetine in the treatment-refractory patients with panic disorder: an open label study
    Dannon, PN
    Iancu, I
    Grunhaus, L
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2002, 17 (07) : 329 - 333
  • [32] Transcutaneous Vagus Nerve Stimulation (taVNS) for Major Depressive Disorder: An Open Label Proof-of-Concept Trial
    Trevizol, Alisson P.
    Shiozawa, Pedro
    Taiar, Ivan
    Soares, Amanda
    Gomes, July S.
    Barros, Mirna D.
    Liquidato, Bianca M.
    Cordeiro, Quirino
    BRAIN STIMULATION, 2016, 9 (03) : 453 - 454
  • [33] Trigeminal Nerve Stimulation (TNS) for Major Depressive Disorder in the Elderly: An Open Label Proof-of-Concept Trial
    Trevizol, Alisson Paulino
    Shiozawa, Pedro
    Cook, Ian A.
    Sato, Isa Albuquerque
    de Oliveira Diniz, Breno Satler
    Lowenthal, Rosane
    Barros, Mirna Duarte
    Cordeiro, Quirino
    BRAIN STIMULATION, 2016, 9 (01) : 146 - 147
  • [34] An 8-week, open-label trial of duloxetine for comorbid major depressive disorder and chronic headache
    Volpe, Fernando M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (09) : 1449 - +
  • [35] A randomized open-label trial of paroxetine versus paroxetine plus sulpiride in the treatment of major depressive disorder
    Uchida, H
    Takeuchi, H
    Nomura, K
    Suzuki, T
    Watanabe, K
    Kashima, H
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (03) : A16 - A16
  • [36] An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)
    Carina Joy Donegan
    Dimitri Daldegan-Bueno
    Rachael Sumner
    David Menkes
    William Evans
    Nicholas Hoeh
    Frederick Sundram
    Lisa Reynolds
    Rhys Ponton
    Alana Cavadino
    Todd Smith
    Partha Roop
    Nathan Allen
    Binu Abeysinghe
    Darren Svirskis
    Anna Forsyth
    Mahima Bansal
    Suresh Muthukumaraswamy
    Pilot and Feasibility Studies, 9
  • [37] The Effectiveness and Safety of Adjunctive Aripiprazole in Taiwanese Patients With Antidepressant-Refractory Major Depressive Disorder A Prospective, Open-Label Trial
    Chen, Shaw-Ji
    Hsiao, Yi-Lin
    Shen, Tsu-Wang
    Chen, Shao-Tsu
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (01) : 56 - 60
  • [38] An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)
    Donegan, Carina Joy
    Daldegan-Bueno, Dimitri
    Sumner, Rachael
    Menkes, David
    Evans, William
    Hoeh, Nicholas
    Sundram, Frederick
    Reynolds, Lisa
    Ponton, Rhys
    Cavadino, Alana
    Smith, Todd
    Roop, Partha
    Allen, Nathan
    Abeysinghe, Binu
    Svirskis, Darren
    Forsyth, Anna
    Bansal, Mahima
    Muthukumaraswamy, Suresh
    PILOT AND FEASIBILITY STUDIES, 2023, 9 (01)
  • [39] Major depressive disorder, sleep EEG and agomelatine: an open-label study
    Salva, Maria-Antonia Quera
    Vanier, Bernard
    Laredo, Judith
    Hartley, Sarah
    Chapotot, Florian
    Moulin, Catherine
    Lofaso, Frederic
    Guilleminault, Christian
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2007, 10 (05): : 691 - 696
  • [40] Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study
    Arango, Celso
    Fegert, Joerg M.
    Picarel-Blanchot, Francoise
    Marx, Ute
    Truffaut-Chalet, Lucie
    Penelaud, Pierre-Francois
    Buitelaar, Jan
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2024,
12345